Back to Search
Start Over
Development and Assessment of Nano-Technologies for Cancer Treatment: Cytotoxicity and Hyperthermia Laboratory Studies
- Source :
- Cancer investigation. 38(1)
- Publication Year :
- 2019
-
Abstract
- Cancer treatment by magnetic hyperthermia offers numerous advantages, but for practical applications many variables still need to be adjusted before developing a controlled and reproducible cancer treatment that is bio-compatible (non-damaging) to healthy cells. In this work, Fe3O4 and CoFe2O4 were synthesized and systematically studied for the development of efficient therapeutic agents for applications in hyperthermia. The biocompatibility of the materials was further evaluated using HepG2 cells as biological model. Colorimetric and microscopic techniques were used to evaluate the interaction of magnetic nano-materials (MNMs) and HepG2 cells. Finally, the behavior of MNMs was evaluated under the influence of an alternating magnetic field (AMF), observing a more efficient temperature increment for CoFe2O4, a desirable behavior for biomedical applications since lower doses and shorter expositions to alternating magnetic field might be required.
- Subjects :
- 0301 basic medicine
Hyperthermia
Male
Cancer Research
Materials science
Time Factors
Biocompatibility
Magnetic Field Therapy
Biocompatible Materials
Ferric Compounds
03 medical and health sciences
0302 clinical medicine
Neoplasms
Nano
Materials Testing
Toxicity Tests
medicine
Animals
Humans
Temperature Increment
Cytotoxicity
Magnetite Nanoparticles
Biological modeling
General Medicine
Cobalt
Hep G2 Cells
Hyperthermia, Induced
medicine.disease
Combined Modality Therapy
Ferrosoferric Oxide
Cancer treatment
Rats
030104 developmental biology
Magnetic hyperthermia
Nanomedicine
Oncology
Liver
030220 oncology & carcinogenesis
Colorimetry
human activities
Biomedical engineering
Subjects
Details
- ISSN :
- 15324192
- Volume :
- 38
- Issue :
- 1
- Database :
- OpenAIRE
- Journal :
- Cancer investigation
- Accession number :
- edsair.doi.dedup.....6f36399fd916d9472f161bb536f1c9a6